Management of tubal ectopic pregnancy with methotrexate in the setting of symptomatic Coronavirus disease 2019 (COVID-19): A case report
PDF
Cite
Share
Request
Case Reports
VOLUME: 13 ISSUE: 3
P: 273 - 277
September 2021

Management of tubal ectopic pregnancy with methotrexate in the setting of symptomatic Coronavirus disease 2019 (COVID-19): A case report

Facts Views Vis ObGyn 2021;13(3):273-277
1. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Miami, Health Systems, Jackson Memorial Hospital, Miami, Florida
No information available.
No information available
PDF
Cite
Share
Request

Abstract

Background: Coronavirus Disease 2019 (COVID-19) represents a complex therapeutic challenge. As the pandemic progresses, patients are presenting with ectopic pregnancies (EPs) and symptomatic COVID-19.

Objective: We present the management of a patient with multiple medical comorbidities and tubal EP in the setting of severe symptomatic COVID-19 infection where all management options were precluded.

Methods: Case report with literature review of management of tubal EP in the setting of severe symptomatic COVID-19 infection.

Result: After careful consideration of options, the patient underwent successful medical management with methotrexate while receiving supportive care for COVID-19.

Conclusions: Methotrexate proved to be the safest therapeutic option in this patient. Management of patients with severe COVID-19 and gynaecologic emergencies should be individualised and carefully reviewed with evolving knowledge of COVID-19.

Keywords:
Methotrexate, ectopic pregnancy, coronavirus